Last update :
19/11/2024
Antibiotic   Teicoplanine  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Bactomax Brazil
Celplanin Austria, India, Peru
Heptacidin Mexico
Koplan Brazil
Pitil Chile
Plavital Mexico
Sinbaken Mexico
Targocid Argentina, Australia, Austria, Belgium, Brazil, Chile, Colombia, Croatia, Denmark, Egypt, Finland, France, Great Britain, Greece, Hungary, Iran, Ireland, Luxembourg, Malaysia, Mexico, Morocco, Netherlands, New Zealand, Norway, Poland, Portugal, Slovenia, Spain, Sweden, Switzerland, Thailand, Tunisia, Turkey, United Arab Emirates
Targosid Italy, Portugal
Teicoplanin Germany, Iran
Teicoplanina Chile, Mexico, Spain
Teicox Argentina
Tekosit Turkey
Tepladex Mexico
Teriplax Mexico
Ticocin Venezuela
Zicoplanin India
References   injection   References : Teicoplanine  
Type Publication
289 Journal Jim LK.
Physical and chemical compatibility of intravenous ciprofloxacin with other drugs.
Ann Pharmacotherapy 1993 ; 27: 704-707.
1608 Journal Galanti LM, Hecq JD, Jeuniau P, Vanbeck D, Jamart J.
Assessment of the stability of teicoplanin in intravenous infusions.
Int J Pharm Compound 2001 ; 5: 397-400.
2057 Journal Droste JC, Jeraj HA, MacDonald A, Farrington K.
Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis.
J Antimicrob Chemother 2003 ; 51: 849-855.
2450 Journal Manduru M, Fariello A, White RL, Fox JL, Bosso JA.
Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution
Am J Health-Syst Pharm 1996 ; 53: 2731 - 2734.
3656 Manufacturer Teicoplanine (Targocid®) - Résumé des caractéristiques du produit
Sanofi Aventis France 2014
3728 Journal Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B.
Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3976 Journal Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B.
Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
4440 Journal Omotani S, Aoe M, Esaki S, Nagai K, Hatsuda Y, Mukai J, Teramachi H, Myotoku M.
Compatibility of Intravenous Fat Emulsion with Antibiotics for Secondary Piggyback Infusion.
Ann Nutr Metab 2018 ; 73: 227-233.
4444 Journal Tounian P, Jehl F, Pauliat S, Morgant G, Ghirardi L, Selva M.A, Fontaine J.L, Aymard P, Girardet J.P.
Stability and compatibility of Teicoplanin in parenteral nutrition solutions used in pediatrics.
Clinical Nutrition 1999 ; 19, 3: 159-165.

  Mentions Légales